RIDDLE
Research type
Research Study
Full title
RIDDLE: Robotic Inflammatory bowel Disease Development, Learning and Efficacy Study
IRAS ID
338612
Contact name
Abhilasha Patel
Contact email
Sponsor organisation
University Hospitals Coventry and Warwickshire NHS Trust
Duration of Study in the UK
1 years, 1 months, 30 days
Research summary
Inflammatory bowel disease (IBD) is an incurable health condition. It affects 725 per 100,000 of the UK population and is most common in teenagers and young adults. There are two types of IBD; Crohn's disease (CD) which affects any part of the bowel from the mouth to anus and Ulcerative Colitis (UC) which only affects the large bowel. CD causes inflammation in the entire lining of the bowel which can weaken the bowel wall so that it perforates, often involving nearby organs such as the bladder or vagina. Both types of IBD can require surgery if the inflammation/symptoms stop responding to medical treatment, patients develop complications or if patients prefer to avoid taking strong medications. Keyhole surgery can be done in two ways; laparoscopic surgery where the surgeons use straight instruments through small incisions or robotic surgery where the instruments are attached to a robot and the surgeon controls them away from the patient using controls like a joystick. In this type of surgery, the surgeon cannot feel the tissues like you can in laparoscopic surgery. There is no information available on which of these keyhole procedures is better and how they affect the patient's recovery after surgery. In this study, we will include all IBD patients having keyhole surgery over a 12-month period at several UK hospitals. Details about how the operation was performed and what the outcome was after surgery will be recorded. Patients will be approached throughout the study to assess their recovery and the impact of the surgery on their quality of life. This will enable us to understand how laparoscopic/robotic surgery affects patient outcomes.
REC name
London - Bromley Research Ethics Committee
REC reference
24/PR/0493
Date of REC Opinion
21 May 2024
REC opinion
Further Information Favourable Opinion